id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2013-D-0575-0039,FDA,FDA-2013-D-0575,"Agency Information Collection Activities; Announcement of Office of
Management and Budget Approvals",Notice,Notice of Approval,2018-06-08T04:00:00Z,2018,6,2018-06-08T04:00:00Z,,2018-06-08T12:42:24Z,2018-12338,0,0,090000648337b835
FDA-2013-D-0575-0037,FDA,FDA-2013-D-0575,"Agency Information Collection Activities; Submission for Office of
Management and Budget Review; Comment Request; Guidance for
Industry on Expedited Programs for Serious Conditions—Drugs and
Biologics",Notice,30 Day Proposed Information Collection,2018-02-07T05:00:00Z,2018,2,2018-02-07T05:00:00Z,2018-03-10T04:59:59Z,2018-03-15T01:02:49Z,2018-02415,0,0,0900006482ef68c5